Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?
- 31 March 2002
- journal article
- other
- Published by Elsevier in Journal of Hepatology
- Vol. 36 (3) , 445-446
- https://doi.org/10.1016/s0168-8278(01)00283-5
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adwThe Lancet, 2001
- Early Detection of Viral Resistance by Determination of Hepatitis B Virus Polymerase Mutations in Patients Treated by Lamivudine for Chronic Hepatitis BHepatology, 2000
- Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis BGastroenterology, 2000
- THERAPY WITH NUCLEOSIDE ANALOGUES FOR HEPATITIS B VIRUS INFECTIONClinics in Liver Disease, 1999
- Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapyJournal of Hepatology, 1998
- EFFICACY OF LAMIVUDINE IN CHRONIC HEPATITIS B PATIENTS WITH ACTIVE VIRAL REPLICATION AND DECOMPENSATED CIRRHOSIS UNDERGOING LIVER TRANSPLANTATION1Transplantation, 1996
- Typing Hepatitis B Virus by Homology in Nucleotide Sequence: Comparison of Surface Antigen SubtypesJournal of General Virology, 1988